Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus

被引:90
作者
de Leeuw, K.
Freire, B.
Srnit, A. J.
Bootsma, H.
Kallenberg, C. G.
Bijl, M.
机构
[1] Univ Groningen, Med Ctr, Dept Internal Med, Div Clin Immunol, NL-9713 GZ Groningen, Netherlands
[2] Univ Groningen, Med Ctr, Dept Internal Med, Div Rheumatol, NL-9713 GZ Groningen, Netherlands
[3] Univ Groningen, Med Ctr, Dept Internal Med, Div Vasc Dis, NL-9713 GZ Groningen, Netherlands
基金
巴西圣保罗研究基金会;
关键词
atherosclerosis; risk factors; systemic lupus erythematosus;
D O I
10.1177/0961203306069972
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine risk factors of accelerated atherosclerosis in patients with systemic lupus erythematosus (SLE), 72 patients with inactive disease and 36 age- and sex-matched controls were included. The intima-media thickness (IMT) of the common carotid artery was determined by ultrasound. Traditional risk factors and disease-related factors were recorded. Cardiovascular risk was estimated using SCORE (systematic coronary risk evaluation). Markers of inflammation, endothelial activation and vascular remodelling (matrix metalloproteinases (MMP-3, MMP-9) and tissue inhibitor of metal loproteinase-1 (TIMP-1)) were determined. IMT was increased in patients (0.67 mm +/- 0. 13 versus 0.61 min 0. 11, P < 0.05). Prevalence of hypertension (33% versus 6%, P < 0.001), SCORE (2.2 (1.7-4.2) versus 1.7 (1.3-2. 1), P < 0.001), as well as parameters of inflammation (CRP 1.8 (0.6-5.8) mg/L versus 0.6 (0.2-1.0) mg/L, P < 0.001) and endothelial activation (VCAM-I 505 (389-683) ng/mL versus 374 (322-427) ng/mL, P < 0.001) and von Willebrand factor (138 (59-208)% versus 48 (24-92)%, P < 0.001), were increased in patients. Vascular remodelling was altered: MMP-3 and TIMP-1 were increased (18 (10-29) ng/mL versus 8 (5-11) ng/mL, P < 0.001, and 275 (216-352) ng/mL versus 230 (197-268) ng/mL, P < 0.001, respectively), and MMP-9 was decreased in SLE (266 (147-412) ng/mL versus 348 (226-530) ng/mL, P < 0.05). Univariate analyses revealed that in patients IMT was associated with age, systolic blood pressure, SCORE and disease duration. In multivariate analysis, age and SCORE were independent predictors of IMT. In conclusion, SLE patients have an increased IMT, which is associated with traditional risk factors. Non-traditional risk factors, such as endothelial activation, altered vascular remodelling and disease duration, might play an additional role.
引用
收藏
页码:675 / 682
页数:8
相关论文
共 34 条
[1]   Systemic lupus erythematosus in three ethnic groups:: III A comparison of characteristics early in the natural history of the LUMINA cohort [J].
Alarcón, GS ;
Friedman, AW ;
Straaton, KV ;
Moulds, JM ;
Lisse, J ;
Bastian, HM ;
McGwin, G ;
Bartolucci, AA ;
Roseman, JM ;
Reveille, JD .
LUPUS, 1999, 8 (03) :197-209
[2]   UP-REGULATION OF ENDOTHELIAL-CELL ADHESION MOLECULES CHARACTERIZES DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - THE SHWARTZMAN PHENOMENON REVISITED [J].
BELMONT, HM ;
BUYON, J ;
GIORNO, R ;
ABRAMSON, S .
ARTHRITIS AND RHEUMATISM, 1994, 37 (03) :376-383
[3]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[4]   Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease - Additive value of flow-mediated dilation to ankle-brachial pressure index [J].
Brevetti, G ;
Silvestro, A ;
Schiano, V ;
Chiariello, M .
CIRCULATION, 2003, 108 (17) :2093-2098
[5]   The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus [J].
Brouwer, JLR ;
Bijl, M ;
Veeger, NJGM ;
Kluin-Nelemans, HC ;
van der Meer, J .
BLOOD, 2004, 104 (01) :143-148
[6]   Risk factors for coronary heart disease in women with systemic lupus erythematosus -: The Toronto Risk Factor Study [J].
Bruce, IN ;
Urowitz, MB ;
Gladman, DD ;
Ibañez, D ;
Steiner, G .
ARTHRITIS AND RHEUMATISM, 2003, 48 (11) :3159-3167
[7]   Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project [J].
Conroy, RM ;
Pyörälä, K ;
Fitzgerald, AP ;
Sans, S ;
Menotti, A ;
De Backer, G ;
De Bacquer, D ;
Ducimetière, P ;
Jousilahti, P ;
Keil, U ;
Njolstad, I ;
Oganov, RG ;
Thomsen, T ;
Tunstall-Pedoe, H ;
Tverdal, A ;
Wedel, H ;
Whincup, P ;
Wilhelmsen, L ;
Graham, IM .
EUROPEAN HEART JOURNAL, 2003, 24 (11) :987-1003
[8]   Accelerated atherosclerosis in patients with Wegener's granulomatosis [J].
de Leeuw, K ;
Sanders, JS ;
Stegeman, C ;
Smit, A ;
Kallenberg, CG ;
Bijl, M .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (05) :753-759
[9]   Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus [J].
Doria, A ;
Shoenfeld, Y ;
Wu, R ;
Gambari, PF ;
Puato, M ;
Ghirardello, A ;
Gilburd, B ;
Corbanese, S ;
Patnaik, M ;
Zampieri, S ;
Peter, JB ;
Favaretto, E ;
Iaccarino, L ;
Sherer, Y ;
Todesco, S ;
Pauletto, P .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (11) :1071-1077
[10]  
Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO